Estimating The Minimally Clinically Important Difference of the Upper Extremity Scale of the Fugl-Meyer Assessment in Chronic, Severe Stroke

Abstract

Date Presented 04/20/2023Accurate estimates of the minimal clinically significant difference (MCID) of the Upper Extremity scale of the Fugl–Myer Assessment are essential for determining the effectiveness of interventions provided to stroke survivors in the chronic phase with residual severe upper extremity hemiparesis. Previously established values cannot be generalized to stroke survivors in other phases of recovery and with differing severity of residual hemiparesis due to the diversity in level of impairment.Primary Author and Speaker: Elliot BardenAdditional Authors and Speakers: Kyle O'LaughlinContributing Authors: Ela Plow, Jayme Knutson, Xiaofeng Wang, Kaitlin Perlic